Search for Clinical Trial Results

Sponsored By

Hyperlipoproteinemia Type I - 48 Studies Found

Status Study
Terminated Study Name: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Condition: Hyperlipoproteinemia Type I
Date: 2011-09-28
Terminated Study Name: Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.
Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Date: 2012-04-27
Interventions: Drug: LCQ908
Recruiting Study Name: Orlistat for the Treatment of Type I Hyperlipoproteinemia
Condition:
  • Hyperlipoproteinemia Type I
  • Hypertriglyceridemia

Date: 2016-05-02
Interventions: Drug: Orlistat Orlistat is a gastric and pancreatic lipase inhibitor that is approved by the FDA for wei
Completed Study Name: The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
Condition: Familial Chylomicronemia Syndrome
Date: 2014-08-05
Interventions:
  • Drug: volanesorsen Other Names
Completed Study Name: A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome
Condition: Familial Chylomicronemia Syndrome (FCS)
Date: 2011-12-21
Interventions:
  • Drug: LCQ908 LCQ908 10 mg, LCQ
Recruiting Study Name: The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
Condition:
  • Familial Chylomicronemia Syndrome
  • Lipopro
    Date: 2016-01-12
    Interventions: Drug: Volanesorsen 300 mg volanesorsen Other Names:
Recruiting Study Name: Alipogene Tiparvovec for the Treatment of LPLD Patients
Condition: LPL Deficiency
Date: 2016-05-10
Interventions:
  • Drug: alipogene tiparvovec A d
Not yet recruiting Study Name: Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment
Condition: Lipoprotein Lipase Deficiency
Date: 2016-01-12
Interventions: Drug: Heparin Participants will be given IV heparin in order to release lipoprotein lipase from capillar
Not yet recruiting Study Name: Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Condition: Familial Lipoprotein Lipase Deficiency
Date: 2010-04-22
Interventions:
  • Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]

Completed Study Name: Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Condition: Familial Lipoprotein Lipase Deficiency
Date: 2009-04-30
Interventions:
  • Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]

Next >>>